Johnson & Johnson (NYSE:JNJ)

During the Trading Day
101.15 +0.02 / +0.02%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
101.09 -0.0641 / -0.06%
 
Volume: 201.8K
Gilead's Sustainable Competitive Advantage
11:59am / MotleyFool.com
Investment Clubs -- Can You Boost Retirement Savings With a Social Network?
May 22 / TheStreet.com
Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog
May 27 / Zacks.com
Reckitt faces regulatory friction in UK over K-Y acquisition
May 22 / FT.com
3 High-Yield, Low-Risk Dividend Stocks for Extreme Safety
May 27 / TheStreet.com
J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog
May 21 / Zacks.com
How to Use Options to Profit From Johnson & Johnson's Success
May 27 / TheStreet.com
Johnson & Johnson Just Stepped Up Its Hepatitis C Game
May 21 / MotleyFool.com
Stocks To Buy For 10 Years: Facebook Inc, Amazon.com, Inc, and Google Inc.
May 27 / MotleyFool.com
PerkinElmer Hits 52-Week High on Strong Q1, Favorable View - Analyst Blog
May 21 / Zacks.com
Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog
May 27 / Zacks.com
Following Hepatitis C, This Could Be the Next Disease Researchers Cure
May 21 / MotleyFool.com
Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog
May 26 / Zacks.com
Johnson & Johnson Takes On Gilead Sciences in Hep C... Again
May 20 / MotleyFool.com
Pfizer and AstraZeneca: one year after deal that never was
May 26 / FT.com
Achillion and Johnson & Johnson in $1.1B HCV Tie-Up - Analyst Blog
May 20 / Zacks.com
Stocks Low But Not Tempting
May 26 / TheStreet.com
Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing
May 20 / MotleyFool.com
Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck
May 26 / TheStreet.com
The 30 Dow Jones Stocks
May 18 / MotleyFool.com
Ugly day for stocks: Everything down as Fed rate hike fears return
May 26 / CNNMoney.com
Apple Inc. Wants Your DNA, but Why?
May 18 / MotleyFool.com
The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuti...
May 26 / Zacks.com
Endo to buy Par from TPG Capital in in $8bn deal
May 18 / FT.com
The Best Stocks for Investing in Banks
May 24 / MotleyFool.com
Most popular stocks: Millennials vs. Boomers
May 14 / CNNMoney.com
Warren Buffett's Portfolio: 3 Biotech Stocks the Oracle of Omaha Could Love
May 24 / MotleyFool.com
European drugmakers lifted by weak euro
Apr 30 / FT.com
3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog
May 22 / Zacks.com
Chinese chase Australian opiates in Hong Kong
Apr 29 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account